(Q34268841)

1 August 2017

1 reference

title

Molecular and pharmacological aspects of antiestrogen resistance (English)

1 reference

1 August 2017

1 reference

Clarke R

1

1 reference

1 August 2017

Skaar TC

2

1 reference

1 August 2017

Bouker KB

3

1 reference

1 August 2017

Davis N

4

1 reference

1 August 2017

Lee YR

5

1 reference

1 August 2017

Welch JN

6

1 reference

1 August 2017

Leonessa F

7

1 reference

1 August 2017

1 January 2001

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

1 August 2017

1 reference

1 August 2017

76

1 reference

1 August 2017

71-84

1 reference

1 August 2017

1-5

1 reference

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Multicenter phase II efficacy trial of toremifene in tamoxifen-refractory patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Meta-analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Adverse events reported by postmenopausal women in controlled trials with raloxifene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Molecular basis of agonism and antagonism in the oestrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Identification of selective estrogen receptor modulators by their gene expression fingerprints

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Acquired estrogen independence and antiestrogen resistance in breast cancer: estrogen receptor driven phenotypes?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Measurement of steroid hormone receptors in breast cancer patients on tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Estrogen receptor distribution in the peripheral, intermediate and central regions of breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Heterogeneous estrogen receptor levels detected via multiple microsamples from individual breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Characterisation of a tamoxifen-resistant variant of the ZR-75-1 human breast cancer cell line (ZR-75-9a1) and ability of the resistant phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Estrogen receptor mutagenesis and hormone resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Estrogen receptor variants

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Identification of twenty alternatively spliced estrogen receptor alpha mRNAs in breast cancer cell lines and tumors using splice targeted primer approach

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Hormonal aspects of breast cancer. Growth factors, drugs and stromal interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Response after withdrawal of tamoxifen and progestogens in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Differential effects of estrogen and antiestrogen on in vitro clonogenic growth of human breast cancers in soft agar.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Analysis of tyrosine kinase mRNAs including four FGF receptor mRNAs expressed in MCF-7 breast-cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

A model to describe how a point mutation of the estrogen receptor alters the structure-function relationship of antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Cloning and characterization of human estrogen receptor beta isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

A comparison of transcriptional activation by ER alpha and ER beta

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Estrogen receptor activation function 1 works by binding p160 coactivator proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Systematic variation in gene expression patterns in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

The inter-relationships between ovarian-independent growth, tumorigenicity, invasiveness and antioestrogen resistance in the malignant progression of human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Nuclear substrates of protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

The major phosphorylation site of nucleophosmin (B23) is phosphorylated by a nuclear kinase II

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Tamoxifen induces selective membrane association of protein kinase C epsilon in MCF-7 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Regulatory cascades involving calmodulin-dependent protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Calmodulin-stimulated phosphorylation of 17 beta-estradiol receptor on tyrosine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Calmodulin is essential for estrogen receptor interaction with its motif and activation of responsive promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Drug toxicity mechanisms in human hepatoma HepG2 cells: cyclosporin A and tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Differential regulation of AP1 activity by retinoic acid in hormone-dependent and -independent breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Repression of gene expression by oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Production of 8-hydroxy-2'-deoxguanosine in DNA by microsomal activation of tamoxifen and 4-hydroxytamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

DNA cleavage and 8-hydroxydeoxyguanosine formation caused by tamoxifen derivatives in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Peroxidase-catalyzed pro- versus antioxidant effects of 4-hydroxytamoxifen: enzyme specificity and biochemical sequelae

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Redox signalling by transcription factors NF-kappa B and AP-1 in lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Endocrine response and resistance in breast cancer: a role for the transcription factor Fos.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Biological and clinical associations of c-jun activation in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

The effects of a constitutive expression of transforming growth factor-alpha on the growth of MCF-7 human breast cancer cells in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Epidermal growth factor in NMU-induced mammary tumors in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Altered MAP kinase (ERK1,2) regulation in primary cultures of mammary tumor cells: elevated basal activity and sustained response to EGF.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Covalent binding of 17 beta-estradiol and retinoic acid to proteins in the human breast cancer cell line MCF-7.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Mechanism for maintenance of high breast tumor estradiol concentrations in the absence of ovarian function: role of very high affinity tissue uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Steroid sequestration and tightly bound oestrogen-protein complexes in human breast tumours and a breast cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

The relationship between 17 beta-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Human breast cancer in the athymic nude mouse: cytostatic effects of long-term antiestrogen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900193-X

7 January 2021

10.1016/S0960-0760(00)00193-X

Identifiers

DOI

1 reference

1 August 2017

1 reference